Smith Asset Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.32M Sell
111,254
-1,470
-1% -$32.6K 1.89% 21
2026
Q2
$2.48M Sell
112,724
-2,537
-2% -$50K 1.95% 22
2026
Q1
$2.05M Sell
115,261
-1,799
-2% -$34K 1.76% 23
2025
Q4
$2.22M Sell
117,060
-285
-0.2% -$5.38K 1.83% 23
2025
Q3
$2.17M Sell
117,345
-2,175
-2% -$35.5K 1.85% 24
2025
Q2
$1.85M Sell
119,520
-1,199
-1% -$18.6K 1.6% 27
2025
Q1
$1.96M Sell
120,719
-2,362
-2% -$40.6K 1.85% 23
2024
Q4
$1.98M Buy
+123,081
New +$2.18M 1.92% 19

Other funds holding HQH

Smith Asset Management's HQH Position: Q3 2026 in Review

Smith Asset Management reduced its abrdn Healthcare Investors (HQH) stake by 1.3% in Q3 2026, selling an estimated $32.6K and leaving 111,254 shares worth $2.32M. The position accounts for 1.89% of the portfolio, ranked #21.

Smith Asset Management first reported a position in HQH in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.48M in Q2 2026. 102 funds tracked by Wall St. Rank hold HQH as of Q3 2026.

  • Smith Asset Management held 111,254 shares of abrdn Healthcare Investors worth $2.32M as of Q3 2026.
  • Smith Asset Management sold 1,470 abrdn Healthcare Investors shares in Q3 2026, an estimated $32.6K.
  • abrdn Healthcare Investors made up 1.89% of Smith Asset Management's portfolio in Q3 2026, its #21 holding.
  • Smith Asset Management first reported a position in abrdn Healthcare Investors in Q4 2024 and has held it in 8 quarters since.
  • Smith Asset Management's abrdn Healthcare Investors position peaked at $2.48M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2026.

Based on Smith Asset Management's 13F filing for Q3 2026, filed 16 Oct 2026.